Insight Molecular Diagnostics Inc.
IMDX
$4.01
$0.174.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 239.00K | 32.00K | 1.14M | 260.00K | 518.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 239.00K | 32.00K | 1.14M | 260.00K | 518.00K |
| Cost of Revenue | 82.00K | 17.00K | 643.00K | 121.00K | 180.00K |
| Gross Profit | 157.00K | 15.00K | 496.00K | 139.00K | 338.00K |
| SG&A Expenses | 4.79M | 5.39M | 4.62M | 3.93M | 4.11M |
| Depreciation & Amortization | -- | -- | 0.00 | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.36M | 10.36M | 22.26M | 7.93M | 7.56M |
| Operating Income | -9.12M | -10.33M | -19.98M | -7.67M | -7.04M |
| Income Before Tax | -11.26M | -4.29M | -22.96M | -10.85M | -9.74M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.26M | -4.29M | -22.96M | -10.85M | -9.74M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.26M | -4.29M | -22.96M | -10.85M | -9.74M |
| EBIT | -9.12M | -10.33M | -19.98M | -7.67M | -7.04M |
| EBITDA | -8.45M | -9.70M | -18.86M | -7.09M | -6.48M |
| EPS Basic | -0.31 | -0.12 | -0.72 | -0.34 | -0.30 |
| Normalized Basic EPS | -0.15 | -0.18 | -0.18 | -0.15 | -0.14 |
| EPS Diluted | -0.31 | -0.12 | -0.72 | -0.34 | -0.30 |
| Normalized Diluted EPS | -0.15 | -0.18 | -0.18 | -0.15 | -0.14 |
| Average Basic Shares Outstanding | 36.75M | 34.52M | 32.07M | 32.03M | 32.02M |
| Average Diluted Shares Outstanding | 36.75M | 34.52M | 32.07M | 32.03M | 32.02M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |